Summary
For Year 2026-27, Mangalam Drugs And Organics reports the following shareholding: Total Promoters at 35.65%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.32%, Domestic Institutional Investors at 0%, and Retail at 64.02%. This breakdown provides a quick snapshot of ownership distribution for Mangalam Drugs And Organics in 2026-27.
Mangalam Drugs And Organics FAQs
As of 04-2026, the promoter shareholding in Mangalam Drugs And Organics stands at 35.65% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Mangalam Drugs And Organics is 0.32% and 0% respectively.
The retail shareholding of the Mangalam Drugs And Organics is 64.02%.
Changes in shareholding patterns of Mangalam Drugs And Organics can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Mangalam Drugs And Organics are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Mangalam Drugs And Organics Associated Pages
- Mangalam Drugs And Organics Share Price
- Mangalam Drugs And Organics Share Price chart
- Mangalam Drugs And Organics Fundamental Analysis
- Mangalam Drugs And Organics Technical Analysis
- Mangalam Drugs And Organics Peer Comparison
- Mangalam Drugs And Organics Share Price History
- Mangalam Drugs And Organics Board of Directors
